We are delighted to announce
that GxP, a leading international provider of compliance services to
the healthcare sector for 10 years, is expanding the range
of services offered. GxP has increased its capabilities and service
offerings in a number of consulting and training areas to support
the entire drug and device development cycle. We are expanding
services areas while maintaining customer support in Europe and now
the US, having recently opened an office in Irvine, California. GxP
has a network of over 50 consultants and has broadened its reach
from
a UK-focused small business to an international organisation.
Some of the new services GxP
now offers are as follows:
· Clinical
technology consulting, headed by
Dr Neil Rotherham
· Biopharmaceutical
process development, headed by Dr
Stephen Collins
· Strategic
planning consulting, headed by Jim
Stracey
With a wealth of
industry knowledge GxP is ideally placed to not only provide regulatory
compliance but also to advise companies on optimal and
cost-effective solutions, as we move into our second decade.
We also offer capabilities in:
Computer systems
validation, headed by Mark WrightRegulatory & validation
project management, headed by Dr Tom DineQualified Person (QP) services
, headed by Dr Anthony Gasson